| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,348 |
19,991 |
$1.29M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,472 |
14,945 |
$695K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
19,998 |
14,712 |
$194K |
| 95930 |
|
4,619 |
2,301 |
$173K |
| 92587 |
|
18,519 |
9,583 |
$157K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,001 |
7,171 |
$135K |
| 99188 |
|
4,855 |
4,816 |
$125K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,476 |
2,447 |
$124K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
12,884 |
12,694 |
$117K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
776 |
765 |
$103K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,851 |
1,826 |
$100K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,324 |
1,319 |
$83K |
| 99173 |
|
4,249 |
4,169 |
$68K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
972 |
941 |
$55K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
920 |
907 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,099 |
1,092 |
$18K |
| 94760 |
|
9,023 |
8,534 |
$17K |
| 87430 |
|
1,153 |
1,143 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
248 |
243 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
442 |
437 |
$9K |
| 90834 |
Psychotherapy, 45 minutes with patient |
74 |
60 |
$9K |
| 96127 |
|
869 |
795 |
$9K |
| 90461 |
|
468 |
454 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
100 |
100 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
165 |
163 |
$7K |
| 85018 |
|
1,795 |
1,759 |
$4K |
| 0072A |
|
83 |
81 |
$4K |
| 0071A |
|
76 |
65 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
40 |
37 |
$2K |
| 99177 |
|
471 |
471 |
$2K |
| 0154A |
|
12 |
12 |
$550.44 |
| 90832 |
Psychotherapy, 30 minutes with patient |
13 |
13 |
$407.16 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
24 |
23 |
$397.96 |
| 83655 |
|
27 |
26 |
$277.68 |
| 87807 |
|
14 |
14 |
$150.15 |
| 92567 |
|
12 |
12 |
$150.12 |
| 90661 |
|
233 |
223 |
$98.91 |
| 83718 |
|
12 |
12 |
$79.42 |
| 82465 |
|
15 |
15 |
$68.87 |
| 90686 |
|
3,080 |
3,046 |
$19.58 |
| 90670 |
|
145 |
140 |
$0.00 |
| 90648 |
|
120 |
115 |
$0.00 |
| 90633 |
|
41 |
39 |
$0.00 |
| 90649 |
|
13 |
13 |
$0.00 |
| 91311 |
|
13 |
13 |
$0.00 |
| 36416 |
|
2,124 |
2,082 |
$0.00 |
| 91315 |
|
14 |
12 |
$0.00 |
| 99000 |
|
413 |
394 |
$0.00 |
| 91307 |
|
192 |
171 |
$0.00 |
| 90651 |
|
17 |
17 |
$0.00 |
| 90656 |
|
23 |
23 |
$0.00 |
| 90677 |
|
14 |
14 |
$0.00 |
| 90619 |
|
39 |
38 |
$0.00 |